Zhongchao Inc. Overview
Pro stress-test →Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. The company operates a dual business model combining medical professional training and pharmaceuticals, serving healthcare practitioners and patients through digital and in-person platforms.
Strategic Profile
Pro stress-test →The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. In June 2026, shareholders approved a major capital increase and flexible share consolidation framework, with the company implementing a 1-for-31 share consolidation to maintain Nasdaq listing. The company faces scaling challenges typical of China-focused digital health platforms.
Competitive Landscape
Pro stress-test →Zhongchao competes in the fragmented Chinese digital health and medical education market against both domestic players (WeChat Health, Dingxiang Doctor) and international telemedicine platforms. Its MDMOOC brand and professional training focus differentiate it, but scale and capital constraints limit competitive reach against well-funded rivals. Key advantages include established pharma partnerships and regulatory approval for pharmaceutical sales.
Industry Context
Zhongchao Inc. operates in Digital health and medical education platforms.
Key facts
Founded: 2012 · Headquarters: Shanghai, China · Employees: Not disclosed · Revenue: Not disclosed; estimate based on microcap trading $10M–$30M range (unverified) · Market cap: N/A